Medprin Regenerative Medical Technologies (301033.SZ) subsidiary's three products received EU MDR certification.
Mapu Medical (301033.SZ) announced that its subsidiary Mapu Biotechnology (Germany) Limited has three products...
Medprin Regenerative Medical Technologies (301033.SZ) announced that its subsidiary, Maipu Biotechnology (Germany) Limited, has recently obtained certificates for three products (neurosurgery series products Ruimo, Ruikang, and Jisuting) in accordance with the European Union Medical Device Regulations (referred to as "MDR").
Related Articles
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Guosen: RWA welcomes the era of strict supervision.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Guosen: RWA welcomes the era of strict supervision.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
